Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
fotos caseras de chicas desnudas
Popular Articles
Burdock Root

Lexicon Initiates Phase 2 Clinical Trial Of LX1032 In Patients With Carcinoid Syndrome
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has initiated a Phase 2 clinical trial of LX1032, the company"s oral drug candidate for managing gastrointestinal symptoms associated with carcinoid syndrome. LX1032 is designed to reduce serotonin production in patients with metastatic carcinoid tumors. Elevated levels of serotonin contribute to the gastrointestinal and possibly other symptoms experienced by these patients.
generic viagra online
Yale Researchers Find Key 'Conductor' Of Nature's Synchronicity
Synchronicity in nature is seen in beating hearts, the flashing of fireflies" lights, the ebb and flow of infectious disease-and the simultaneous rise and fall of populations across vast reaches of space. While scientists have identified some factors that account for this melodic phenomenon, they have yet to sort out the relative contribution each plays in this finely tuned orchestra.
News of the day
Fighting The Challenges Of Poverty
It is estimated that 1.4 billion people live in extreme poverty, on less than $2 a day. In 2000, 189 nations declared that they would "free all men, women, and children from the abject and dehumanizing conditions of extreme poverty". These nations signed up to Millennium Development Goals (MDGs) to combat poverty by 2015. To help meet these complex challenges and "make poverty history" more knowledge and evidence is needed. A launch event Wednesday 22nd July 2009 at the Department for International Development (DFID) marks a new phase of research collaboration between the Economic and Social Research Council (ESRC) and DFID which will provide more robust social science research to address poverty alleviation amongst the poorest countries and peoples of the world.
Sexual Health

Bovie Medical Corporation Announces FDA Submission Of Laparoscopic Device For Solid Organ Resection

Bovie Medical Corporation (the "Company") (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, announced a 510K submission to the FDA seeking pre-market clearance for a laparoscopic SEER device for solid organ resection. The laparoscopic SEER is a line extension of the Saline Enhance Electrosurgical Resection (SEER) device that Bovie launched earlier this year and will address the growing market of minimally invasive liver resection. The laparoscopic SEER allows the surgeon to dissect and achieve hemostasis with a single device resulting in less instrument utilization and fewer instrument changes in a minimally invasive approach. The laparoscopic SEER is the second developed product in a series of new products under development based on the sintered steel technology. Andrew Makrides, president of Bovie, stated, "Surgeons response to the SEER has been very positive and this new device will allow us to address their requests for a laparoscopic version." Bovie Medical Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009